Fantastic results! I don’t think it should be overlooked that the data would be very compelling for ODD
- Forums
- ASX - By Stock
- PAA
- Ann: Extension Study Begins, Analysis Suggests Survival Benefit
Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-10
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.90M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 22.0¢ | $78.95K | 358.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 118422 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 71000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 118422 | 0.215 |
5 | 281446 | 0.210 |
5 | 371081 | 0.205 |
12 | 437180 | 0.200 |
11 | 322463 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 71000 | 3 |
0.230 | 173257 | 6 |
0.235 | 55395 | 2 |
0.240 | 159752 | 3 |
0.245 | 196127 | 3 |
Last trade - 10.35am 16/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online